Evidence map›Paper›PMID 40588596›Full record

ArticleArchives of orthopaedic and trauma surgery2025

The impact of in-hospital initiation of a surgeon-led, anti-osteoporotic medication algorithm for patients with fragility hip fractures: a quasi-experimental study.

Ioannis I Daskalakis, Evangelos I Kritsotakis, Johannes D Bastian, Ioannis V Sperelakis, Theodoros H Tosounidis

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ioannis I DaskalakisDepartment of Orthopaedic Surgery, University Hospital of Heraklion, 71500, Heraklion, Crete, Greece.
Evangelos I KritsotakisLaboratory of Biostatistics, Medical School, University of Crete, Heraklion, Greece.
Johannes D BastianDepartment of Orthopaedic Surgery and Traumatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Ioannis V SperelakisDepartment of Orthopaedic Surgery, University Hospital of Heraklion, 71500, Heraklion, Crete, Greece.
Theodoros H TosounidisDepartment of Orthopaedic Surgery, University Hospital of Heraklion, 71500, Heraklion, Crete, Greece. ttosounidis@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSecondary fracture prevention is essential to current hip fracture management. However, many patients are discharged without the appropriate anti-osteoporotic medication (AOM). This study aims to evaluate the impact of the implementation of an in-hospital, surgeon-led AOM algorithm on patients with fragility hip fractures. The three outcome events of interest assessed were (a) the AOM initiation (b) the persistence to medication at 2 years of follow-up and (c) the secondary fracture incidence within 2 years of AOM initiation in the treated and control groups. MATERIALS AND

methodsThis was a three-arm controlled before-after quasi-experimental study. A group of hospitalized patients with low-energy hip fractures who were prescribed AOM according to the surgeon-led AO algorithm between March 2020 and May 2022, were compared with a group of concurrent control patients who refused the treatment over the same 2 year period, and a group of historical control patients who were hospitalized for hip fragility fractures in 2 years before the algorithm was introduced (February 2018 to February 2020). AOM initiation rates, 2 year medication persistence, and risks of secondary osteoporotic fracture were assessed and compared between groups.

resultsIn this study, we enrolled 598 patients (mean age 82 ± 8 years, 78% female). Post-fracture AOM initiation increased from 15% (41/281) before to 67% (213/317) after introducing the algorithm. Medication persistence after 2 years of AOM initiation was 56% (95% confidence interval [CI] 49-63%) in treated patients and 52% (95% CI 36-66%) in historical controls. Secondary osteoporotic fractures occurred in 15/213 (7%) treated patients, 8/104 (8%) concurrent control patients, and 20/281 (7%) historical-control patients over an average follow-up of 20.4 months. Multivariable Cox regression analysis did not demonstrate significantly different fracture risks in historical controls (cause-specific hazard ratio [csHR] 0.92; 95%CI 0.45-1.89) or concurrent controls (csHR 1.08; 95% CI 0.45-2.57) compared to treated patients.

conclusionThe AO Foundation algorithm can increase AOM initiation at hospital discharge, retaining high medication persistence 2 years post-fracture. A longer follow-up period is required to evaluate the algorithm's effect on secondary fracture prevention.

Indexed as

AlgorithmsBone Density Conservation AgentsHip FracturesOsteoporosisOsteoporotic FracturesSecondary PreventionAgedAged, 80 and overFemaleHospitalizationHumansMaleBone Density Conservation AgentsAntiosteoporosis medicationFragility fractureHip fractureMedication persistenceOsteoporosisSecondary fracture

Identifiers

PMID40588596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.